The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity: Beckendorf V, Guerif S, Le Prise E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P, Centre Alexis Vautrin, Vandoeuvre les Nancy, Nancy, France Journal Article


Author: Zelefsky, M.
Article Title: The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity: Beckendorf V, Guerif S, Le Prise E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P, Centre Alexis Vautrin, Vandoeuvre les Nancy, Nancy, France
Keywords: controlled study; major clinical study; clinical trial; cancer localization; disease classification; note; cancer radiotherapy; comparative study; radiation dose; cancer staging; controlled clinical trial; nephrotoxicity; randomized controlled trial; radiation injury; risk assessment; prostate cancer; prescription; correlation analysis; sexual dysfunction; scoring system; patient compliance; hospital admission; multivariate analysis; symptomatology; randomization; acute toxicity; radiation dose distribution; bladder disease; histogram; rectum disease; human; male; priority journal
Journal Title: Urologic Oncology: Seminars and Original Investigations
Volume: 23
Issue: 4
ISSN: 1078-1439
Publisher: Elsevier Inc.  
Date Published: 2005-07-01
Start Page: 307
Language: English
DOI: 10.1016/j.urolonc.2005.05.014
PROVIDER: scopus
DOI/URL:
Notes: Note -- Export Date: 14 August 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael J Zelefsky
    754 Zelefsky